Rheumatoid Arthritis

Postvaccination anti-S IgG levels predict anti-SARS-CoV-2 neutralising activity over 24 weeks in patients with RA
Kristin Schmiedeberg, Irene A Abela, Natalia Barbara Pikor, Nicolas Vuilleumier, Magdalena Schwarzmueller, Selina Epp, Sabrina Pagano, Sarah Grabherr, Angelica Brooke Patterson, Madalina Nussberger, Alexandra Trkola, Burkhard Ludewig, Johannes von Kempis, Andrea Rubbert-Roth

RMD Open Oct 2022, 8 (2) e002575; DOI: 10.1136/rmdopen-2022-002575
Risk of lung cancer in rheumatoid arthritis and in relation to autoantibody positivity and smoking
Katerina Chatzidionysiou, Daniela di Giuseppe, Jonas Soderling, Anca Catrina, Johan Askling

RMD Open Oct 2022, 8 (2) e002465; DOI: 10.1136/rmdopen-2022-002465
Differential expansion of T peripheral helper cells in early rheumatoid arthritis and osteoarthritis synovium
William Murray-Brown, Yanxia Guo, Annabelle Small, Katie Lowe, Helen Weedon, Malcolm D Smith, Susan E Lester, Susanna M Proudman, Navin L Rao, Ling-Yang Hao, Sunil Nagpal, Mihir D Wechalekar

RMD Open Oct 2022, 8 (2) e002563; DOI: 10.1136/rmdopen-2022-002563
Reduced humoral response to a third dose (booster) of SARS-CoV-2 mRNA vaccines by concomitant methotrexate therapy in elderly patients with rheumatoid arthritis
David Stahl, Carola tho Pesch, Carolin Brück, Ruth L Esser, Jan Thiele, Veronica Di Cristanziano, David M Kofler

RMD Open Oct 2022, 8 (2) e002632; DOI: 10.1136/rmdopen-2022-002632
Prevalence of sarcopenia in patients with rheumatoid arthritis using the revised EWGSOP2 and the FNIH definition
Roswitha Dietzel, Sabine Wiegmann, Diana Borucki, Christian Detzer, Kim Nikola Zeiner, Désirée Schaumburg, Bjoern Buehring, Frank Buttgereit, Gabriele Armbrecht

RMD Open Sep 2022, 8 (2) e002600; DOI: 10.1136/rmdopen-2022-002600
Novel insight into the aetiology of rheumatoid arthritis gained by a cross-tissue transcriptome-wide association study
Jing Ni, Peng Wang, Kang-Jia Yin, Xiao-Ke Yang, Han Cen, Cong Sui, Guo-Cui Wu, Hai-Feng Pan

RMD Open Sep 2022, 8 (2) e002529; DOI: 10.1136/rmdopen-2022-002529
Machine learning predicts response to TNF inhibitors in rheumatoid arthritis: results on the ESPOIR and ABIRISK cohorts
Vincent Bouget, Julien Duquesne, Signe Hassler, Paul-Henry Cournède, Bruno Fautrel, Francis Guillemin, Marc Pallardy, Philippe Broët, Xavier Mariette, Samuel Bitoun

RMD Open Aug 2022, 8 (2) e002442; DOI: 10.1136/rmdopen-2022-002442
'Difficult to treat' rheumatoid arthritis: current position and considerations for next steps
Yvonne Tan, Maya H Buch

RMD Open Jul 2022, 8 (2) e002387; DOI: 10.1136/rmdopen-2022-002387
Biological treatment usage in patients with HIV and rheumatic disease, 2003–2021: long-term safety and follow-up
Benjamin Sornrung Naovarat, Gloria Salazar, Mariko Ishimori, Francis M Williams, John D Reveille

RMD Open Jul 2022, 8 (2) e002282; DOI: 10.1136/rmdopen-2022-002282
Meaning of patient global assessment when joint counts are low in rheumatoid arthritis
David Felson, Vivi Feathers, Chinmayi Naik, Daniel H Solomon, Michael E Weinblatt, Nancy Shadick

RMD Open Jun 2022, 8 (2) e002346; DOI: 10.1136/rmdopen-2022-002346

Main menu

Rheumatoid Arthritis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Rheumatoid Arthritis

Pages